Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan

Hisashi YamanakaInstitute of Rheumatology, Tokyo Women's Medical University, TokyoJapanCorrespondence[email protected]

Masayoshi HarigaiDepartment of Pharmacovigilance, Tokyo Medical Dental University Graduate School, Tokyo, Japan

Naoki IshiguroDepartment of Orthopedic Surgery and Rheumatology, Nagoya University School of Medicine, Nagoya, Japan

Shigeko InokumaJapanese Red Cross Medical Center, Tokyo, Japan

Syuji TakeiDepartment of Pediatrics, Kagoshima University School of Health Science, Kagoshima, Japan

Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan

Yoshiya TanakaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

Haruko SuzukiAbbVie GK, Tokyo, Japan

Yasuhiko ShinmuraAbbVie GK, Tokyo, Japan

Takao KoikeNTT Sapporo Medical Center, Sapporo, Japan

show all

Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date